A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer

35Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Telomere dysfunction is a key mechanism in cancer development. The human telomerase reverse transcriptase (TERT) is the rate-limiting catalytic subunit of the telomerase enzyme, which is necessary for the maintenance of telomere DNA length, chromosomal stability, and cellular immortality. In our attempt to identify functional polymorphisms in the TERT gene and their effect on breast cancer risk, we sequenced the promoter of the gene and identified three single nucleotide polymorphisms (SNPs) with a frequency of at least 10%. One of these SNPs, rs2853669 (-244 T > C), has been shown to affect telomerase activity and telomere length. Recently, this SNP has been suggested to affect familial breast cancer risk. In our case-control study using two large breast cancer sample series, including one with 841 cases with inherited susceptibility to breast cancer, we did not find any association with familial or sporadic breast cancer risk. This well-powered study excludes an effect of the functional -244 T > C SNP and two other correlated SNPs on breast cancer risk. © 2009 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Varadi, V., Brendle, A., Grzybowska, E., Johansson, R., Enquist, K., Butkiewicz, D., … Försti, A. (2009). A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer. Cancer Genetics and Cytogenetics, 190(2), 71–74. https://doi.org/10.1016/j.cancergencyto.2008.12.006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free